Fig. 1From: Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasiaPatients included in the study. AAB: Alpha -blocker; AM: Antimuscarinic, LUTS: Lower Urinary Tract SymptomBack to article page